VVT Med Inc. (TSXV:VVTM)
Canada · Delayed Price · Currency is CAD 0.2000
+0.0100 (5.26%)
At close: Sep 2, 2026
VVT Med Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash & Equivalents | 0.01 | 0.15 | 0.1 | 0.07 |
Cash & Short-Term Investments | 0.01 | 0.15 | 0.1 | 0.07 |
Cash Growth | - | 39.42% | 46.48% | - |
Accounts Receivable | 0.03 | 0.03 | 0.03 | 0.03 |
Other Receivables | 0.04 | 0.04 | 0.02 | 0.02 |
Receivables | 0.07 | 0.07 | 0.05 | 0.05 |
Inventory | 0.3 | 0.28 | 0.22 | 0.2 |
Other Current Assets | - | - | - | 0.02 |
Total Current Assets | 0.38 | 0.5 | 0.37 | 0.34 |
Property, Plant & Equipment | 0.41 | 0.38 | 0.39 | 0.33 |
Long-Term Deferred Charges | - | - | 0.19 | 0.19 |
Other Long-Term Assets | 0.05 | 0.04 | 0.04 | 0.04 |
Total Assets | 0.83 | 0.92 | 0.99 | 0.89 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Accounts Payable | 0.81 | 1.1 | 0.5 | 0.58 |
Accrued Expenses | - | 0.37 | 0.45 | 0.45 |
Short-Term Debt | 0.68 | 0.6 | 5.5 | 3.37 |
Current Portion of Leases | 0.22 | 0.21 | 0.17 | 0.12 |
Other Current Liabilities | 0.68 | 0.22 | 0.09 | 0.04 |
Total Current Liabilities | 2.4 | 2.49 | 6.71 | 4.55 |
Long-Term Debt | - | - | 0.37 | 1.34 |
Long-Term Leases | 0.26 | 0.25 | 0.29 | 0.26 |
Other Long-Term Liabilities | - | - | - | 0.1 |
Total Liabilities | 2.66 | 2.74 | 7.37 | 6.25 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Common Stock | 23.98 | 22.93 | 13.6 | 0.01 |
Additional Paid-In Capital | - | - | - | 13.52 |
Retained Earnings | -25.75 | -24.64 | -20.66 | -19.62 |
Comprehensive Income & Other | -0.05 | -0.11 | 0.69 | 0.72 |
Total Common Equity | -1.83 | -1.82 | -6.38 | -5.37 |
Shareholders' Equity | -1.83 | -1.82 | -6.38 | -5.36 |
Total Liabilities & Equity | 0.83 | 0.92 | 0.99 | 0.89 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Total Debt | 1.17 | 1.06 | 6.32 | 5.09 |
Net Cash (Debt) | -1.16 | -0.91 | -6.22 | -5.02 |
Net Cash Growth | - | - | - | - |
Net Cash Per Share | -0.00 | -0.02 | -0.23 | -1.15 |
Filing Date Shares Outstanding | 71.44 | 66.93 | 6.2 | 4.36 |
Total Common Shares Outstanding | 71.44 | 66.93 | 4.84 | 4.36 |
Working Capital | -2.02 | -2 | -6.34 | -4.21 |
Book Value Per Share | -0.03 | -0.03 | -1.32 | -1.23 |
Tangible Book Value | -1.83 | -1.82 | -6.38 | -5.37 |
Tangible Book Value Per Share | -0.03 | -0.03 | -1.32 | -1.23 |
Machinery | - | 0.37 | 0.32 | 0.32 |